GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

51

ACLF - Nat.Rev.Gastro Hepato Jan 2026

Acute-on-Chronic Liver Failure (ACLF) is a severe and complex syndrome that occurs in patients with pre-existing chronic liver disease or cirrhosis. It is characterized by acute hepatic decompensation,...

52

Nutrition in Cirrhosis - Hepatology Dec 2025

Nutrition in Cirrhosis and Liver Transplantation: Cirrhosis is a condition characterized by severe liver dysfunction, often leading to malnutrition, sarcopenia (low muscle mass), and physical frailty. These conditions...

53

Human Albumin Solutions in Cirrhosis liver - Hept.Comm. Feb.2026

Human Albumin Solutions (HAS): Human Albumin Solution (HAS) is a sterile, purified preparation of human serum albumin, a protein derived from plasma. Albumin plays a critical role in...

54

Acute-on-Chronic Liver Failure: Pathophysiology and Management

Acute-on-Chronic Liver Failure (ACLF) is a distinct clinical syndrome characterized by the rapid deterioration of liver function in patients with pre-existing chronic liver disease or cirrhosis. This condition...

55

Plasma exchange and Survival- real world data

The real-world data on plasma exchange (PEX) in the context of acute liver failure (ALF) suggests that while PEX may provide certain physiological and clinical benefits, it does...

56

Peripheral Venous Access for Low-Volume Plasma Exchange in Liver Disease

Peripheral venous access for low-volume plasma exchange (PLEX) in liver disease represents a promising approach to address the challenges associated with central venous catheterization, particularly in patients with...

57

Noninvasive Markers of Portal Hypertension and Varices in Noncirrhotic Disease

Noncirrhotic portal hypertension (NCPH) encompasses a range of disorders affecting the hepatic portosinusoidal vascular system, leading to portal hypertension (PH). Unlike cirrhosis, there are no established noninvasive criteria...

58

VanC-IT: A Phase 2 Randomized Trial of Oral Vancomycin in Primary Sclerosing Cholangitis

The VanC-IT trial is a phase 2 clinical study designed to evaluate the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis (PSC), a chronic...

59

Spironolactone, Eplerenone and Ascites

Spironolactone and Eplerenone are both mineralocorticoid receptor antagonists (MRAs) that are commonly used in the management of conditions such as heart failure, hypertension, and ascites due to liver...

60

Plasma Volume expansion in cirrhosis - J of Hepatology - Jan.26

Introduction Plasma volume expansion is a critical therapeutic strategy in the management of acute kidney injury (AKI) in patients with cirrhosis and ascites. AKI in cirrhosis often arises...

Previous
156712
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer